Neurotech International Ltd has released a press release.
Neurotech Expands License with Dolce Cann Global
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurotech International Ltd. on 6ix
Earlier from Neurotech International
- Successful Completion of In Vitro Studies
- Further Success with Preliminary In-vitro Studies
- Voluntary Suspension
- Interim Results and Capital Raising
- Response to ASX Price and Volume Query
Later from Neurotech International
- Quarterly Report and Appendix 4C
- Appendix 4E and Annual Report
- Response to ASX Query Letter
- Application for quotation of securities - NTI
- Appointment of Chief Executive Officer
Follow Neurotech International into a list and get an email when it puts out news.
Follow Neurotech International